Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 6Genitourinary 4Gastrointestinal 4Breast 4Thoracic 3Other solid neoplasm 3Lymphoid 2Dermatologic 2Myeloid 1Head & Neck 1Gynecologic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, T-Cell 1Lymphoma, Large-Cell, Anaplastic 1Leukemia, Myeloid, Acute 1

Interventions

Cyclophosphamide 78Rituximab 61Specimen Handling 49Doxorubicin 42Biopsy 42Vincristine 41Magnetic Resonance Spectroscopy 39Prednisone 37fludarabine 29venetoclax 28obinutuzumab 27Methotrexate 23ibrutinib 22Lenalidomide 21Dexamethasone 21Cytarabine 21blinatumomab 19Etoposide 19zanubrutinib 18merphos 17fludarabine phosphate 17acalabrutinib 17prednylidene 15deltacortene 15X-Rays 14Mercaptopurine 14CT-P10 14Bendamustine Hydrochloride 14pegaspargase 13Calcium Dobesilate 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Practice Guidelines as Topic × Lymphoid × 30 days × Clear all
NCT05428176 2026-06-04

A High Intensity Electronic Health Intervention for the Reduction of Learning Disparities in Childhood Cancer Survivors

City of Hope Medical Center

Phase NA Active not recruiting
332 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06724237 2026-05-15

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

Eastern Cooperative Oncology Group

Phase 3 Recruiting
294 enrolled
Lymphoid

Lymphoma, T-Cell, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡